SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CONTOLI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.204
EU - Europa 2.316
AS - Asia 1.729
OC - Oceania 16
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 6
AF - Africa 2
Totale 13.280
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.174
CN - Cina 787
IT - Italia 709
SG - Singapore 475
UA - Ucraina 448
TR - Turchia 285
DE - Germania 283
GB - Regno Unito 235
SE - Svezia 208
PL - Polonia 147
FI - Finlandia 134
ID - Indonesia 125
FR - Francia 56
CA - Canada 28
BE - Belgio 23
CZ - Repubblica Ceca 19
VN - Vietnam 19
AU - Australia 12
IN - India 11
NL - Olanda 10
LT - Lituania 9
HK - Hong Kong 8
JP - Giappone 7
ES - Italia 6
BR - Brasile 5
RU - Federazione Russa 5
EU - Europa 4
HU - Ungheria 4
IR - Iran 4
MK - Macedonia 4
NZ - Nuova Zelanda 4
IE - Irlanda 3
RO - Romania 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
PT - Portogallo 2
BD - Bangladesh 1
CH - Svizzera 1
CL - Cile 1
DK - Danimarca 1
EG - Egitto 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MA - Marocco 1
MX - Messico 1
PK - Pakistan 1
RS - Serbia 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 13.280
Salva come PNG Salva come JPEG
Città #
Fairfield 1.248
Woodbridge 1.044
Houston 956
Ashburn 602
Jacksonville 556
Chandler 537
Ann Arbor 507
Wilmington 488
Seattle 483
Cambridge 426
Santa Clara 379
Singapore 377
Izmir 186
Nanjing 177
Princeton 169
Ferrara 164
Warsaw 145
Jakarta 125
Beijing 124
Milan 118
New York 103
San Diego 103
Boardman 89
Shanghai 82
Addison 64
Los Angeles 58
Dearborn 55
Nanchang 49
Shenyang 47
Mountain View 35
Washington 35
Tianjin 31
Changsha 30
Hebei 30
Jiaxing 29
London 29
Redwood City 28
Falls Church 26
Bologna 24
Brussels 23
Helsinki 23
Norwalk 22
Jinan 21
Frankfurt am Main 20
Bremen 19
Orange 18
Dong Ket 16
Kunming 16
Munich 16
Rome 16
Brno 15
Guangzhou 14
Toronto 14
Taizhou 13
Des Moines 12
Lappeenranta 12
Auburn Hills 11
Ningbo 11
Zhengzhou 11
Augusta 10
San Mateo 10
Verona 10
Chicago 9
Parma 9
Council Bluffs 8
Ferrara di Monte Baldo 8
Lanzhou 8
Paris 8
Redmond 8
Florence 7
Catania 6
Hefei 6
Hong Kong 6
Indiana 6
Istanbul 6
Napoli 6
Ottawa 6
Philadelphia 6
Reggio Nell'emilia 6
Tappahannock 6
Vicenza 6
Changchun 5
Kilburn 5
Beauharnois 4
Budapest 4
Hounslow 4
Islington 4
Leawood 4
Lecco 4
Monmouth Junction 4
Olomouc 4
Padova 4
Palermo 4
Rimini 4
Tokyo 4
Wuhan 4
Albano 3
Bari 3
Bozzolo 3
Chiswick 3
Totale 10.316
Salva come PNG Salva come JPEG
Nome #
Value of fiberoptic bronchoscopy in addition to 18F-FDG-PET/CT in the differentiation of solitary pulmonary nodules: a prospective study 305
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease 194
The contribution of small-Airway abnormalities in chronic obstructive pulmonary disease clinical manifestations: More than a functional issue 191
Respiratory muscle training with normocapnic hyperpnea improves ventilatory pattern and thoracoabdominal coordination, and reduces oxygen desaturation during endurance exercise testing in COPD patients 190
Severe pneumonia after intravesical BCG instillation in a patient with invasive bladder cancer: case report and literature review 175
Polmonite da ipersensibilità da antigeni aviari in un italiano adulto 165
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD 162
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells 141
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 139
Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial 139
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 138
Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis 137
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 134
Models of infection and exacerbations in COPD. 133
Deficient antiviral immune responses in childhood: Distinct roles of atopy and asthma 131
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial 131
Rhinovirus vaccination: the case against 129
null 126
Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis 125
Role of Stem Cells in the Pathogenesis of COPD and Pulmonary Emphysema 124
Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up 124
Morte per asma. Parte I: fenotipi clinici, epidemiologia e fattori di rischio. 122
Physiologic Evaluation of Ventilation Perfusion Mismatch and Respiratory Mechanics at Different Positive End-expiratory Pressure in Patients Undergoing Protective One-lung Ventilation 122
null 121
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 120
Immune Response to Mycobacterium tuberculosis Infection in the Parietal Pleura of Patients with Tuberculous Pleurisy 120
A human rhinovirus model of chronic obstructive pulmonary disease exacerbations 118
Relationship between Troponin Elevation, Cardiovascular History and Adverse Events in Patients with acute exacerbation of COPD 117
Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production 114
Airway inflammation and illness severity in response to experimental rhinovirus infection in asthma. 114
null 114
Reducing Agents Decrease the Oxidative Burst and Improve Clinical Outcomes in COPD Patients: A Randomised Controlled Trial on the Effects of Sulphurous Thermal Water Inhalation. 112
Increased expression of aquaporin 5 in bronchial glands of smokers with or without COPD 110
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. 109
Mechanisms of corticosteroid resistance in severe asthma and chronic obstructive pulmonary disease (COPD) 109
Oxidants in asthma and in chronic obstructive pulmonary disease (COPD) 107
Respiratory virus induction of alpha-, beta- and lambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cells. 106
Exacerbations of asthma and chronic obstructive pulmonary disease (COPD): focus on virus induced exacerbations. 105
Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD 104
IFN-alpha/IFN-lambda responses to respiratory viruses in paediatric asthma 104
null 102
Small airway disease in asthma: pathophysiological and diagnostic considerations 102
Molecular mechanisms of respiratory virus-induced asthma and COPD exacerbations and pneumonia 101
Xanthine oxidase activation by HRV16 infection in respiratory epithelial cells 101
Role of xanthine oxidase activation and reduced glutathione depletion in rhinovirus induction of inflammation in respiratory epithelial cells 100
When asthma diagnosis becomes a challenge 100
γδT cells suppress inflammation and disease during rhinovirus-induced asthma exacerbations. 99
Asthma management in a specialist setting: Results of an Italian Respiratory Society survey 99
Airway inflammatory profile is correlated with symptoms in stable COPD: A longitudinal proof-of-concept cohort study 99
Lymphocyte subsets in experimental rhinovirus infection in chronic obstructive pulmonary disease. 98
Anti-SARS-Cov-2 IgA response in tears of COVID-19 patients 98
Role of stem cells in the pathogenesis of chronic obstructive pulmonary disease and of pulmonary emphysema 98
Targeting Th2 cells in asthmatic airways 97
Viral infections in exacerbations of asthma and chronic obstructive pulmonary disease. 97
Models of respiratory infections: Virus-induced asthma exacerbations and beyond 97
Mechanisms of respiratory virus-induced asthma exacerbations 95
ELEMENTI DI VALUTAZIONE E DIAGNOSTICA FUNZIONALE DELL’APPARATO RESPIRATORIO 95
Overview of the pharmacological challenges facing physicians in the management of patients with concomitant cardiovascular disease and chronic obstructive pulmonary disease 95
Is Peripheral Oxygen Saturation a Reliable Predictor of Upper Airways Air-Flow Limitation? 95
Circulating Endothelial Stem Cells in Age-Matched Smokers with or without Mild-to-Moderate Pulmonary Emphysema 94
Increased deposition of activated complement in peripheral lung vessels of smokers 94
Interleukin-4 Modulates Rhinovirus Replication and Antiviral Immune Response in Respiratory Epithelial Cells 93
Right Ventricle Function in Patients with Acute Coronary Syndrome and Concomitant Undiagnosed Chronic Obstructive Pulmonary Disease 92
Rhinovirus-induced bronchial mucosal inflammatory response in asthma 91
Neutrophil adhesion molecules in experimental rhinovirus infection in COPD. 90
null 90
Symptom variability and control in COPD: Advantages of dual bronchodilation therapy 90
null 88
Rhinovirus-induced interferon production in asthma 87
null 87
Cellule staminali e patologia polmonare dell’adulto 86
A simple method for home exercise training in patients with chronic obstructive pulmonary disease: One-year study 86
Bronchial epithelial cells from asthmatic children have a deficient innate immune response to rhinovirus infection 86
Ruolo dello stress ossidativo nella patogenesi delle broncopneumopatie croniche ostruttive in fase stabile. 86
Do small airway abnormalities characterize asthma phenotypes? In search of proof. 85
Asthma: A Chronic Infectious Disease? 84
Effects of aclidinium on determinants of COPD severity: Symptoms and quality of life 84
null 83
Effects of Anti-IL-5 on Virus-induced Exacerbation in Asthma Light and Shadow 83
Use of ICS in COPD: From Blockbuster Medicine to Precision Medicine 82
Rhinovirus Infection Induces Degradation of Antimicrobial Peptides and Secondary Bacterial Infection in Chronic Obstructive Pulmonary Disease 81
Healthcare costs of the SATisfaction and adherence to COPD treatment (SAT) study follow-up 81
Interactions of airway pathogens and inflammatory processes 81
Pathophysiology of viral-induced exacerbations of COPD 80
The small airways and distal lung compartment in asthma and COPD: A time for reappraisal 80
Withdrawal of inhaled corticosteroids in COPD: A meta-analysis 80
Deficient immune response to viral infections in children predicts later Asthma persistence 80
Morte per asma. Parte II: patogenesi, quadro anatomo-patologico, diagnosi differenziale e prevenzione. 77
Midazolam in flexible bronchoscopy premedication: effects on patient-related and procedure-related outcomes. 77
Update in asthma 2016 76
Interactions of airway pathogens and inflammatory processes 75
Disease awareness in patients with COPD: measurement and extent 74
null 71
Role of deficient type III interferon-lambda production in asthma exacerbations 70
null 70
Satisfaction with chronic obstructive pulmonary disease treatment: results from a multicenter, observational study 70
Effects of bronchodilation on biomarkers of peripheral airway inflammation in COPD 69
Clinical and Functional Characteristics of COPD Patients Across GOLD Classifications: Results of a Multicenter Observational Study 69
Bronchial mucosal IFN-α/β and pattern recognition receptor expression in patients with experimental rhinovirus-induced asthma exacerbations 68
Expression and activation of the major subunit of NF-kB, protein p65, in COPD bronchial glands 67
Totale 10.586
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.109
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.235
Totale 77.344
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.995 0 0 0 0 237 526 282 294 246 249 86 75
2020/20212.212 126 132 170 247 155 181 103 261 74 305 266 192
2021/20221.529 74 125 108 140 56 80 85 98 65 116 160 422
2022/20231.438 185 62 69 145 205 192 107 117 174 26 104 52
2023/2024980 74 107 48 29 59 170 38 68 34 34 49 270
2024/20251.238 100 107 363 166 502 0 0 0 0 0 0 0
Totale 13.661